Although response to treatment based on MRD is considered essential for risk group stratification in current protocols for childhood ALL, the innate characteristics of leukemic cells, including additional karyotypic abnormalities5 and deletion of IKZF-1 20, might also be informative for the prediction of outcomes in patients with Ph+ALL. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.